Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Veracyte (VCYT) FCF Margin (2016 - 2025)

Historic FCF Margin for Veracyte (VCYT) over the last 14 years, with Q3 2025 value amounting to 31.82%.

  • Veracyte's FCF Margin rose 79000.0% to 31.82% in Q3 2025 from the same period last year, while for Sep 2025 it was 19.83%, marking a year-over-year increase of 65600.0%. This contributed to the annual value of 14.31% for FY2024, which is 48300.0% up from last year.
  • Latest data reveals that Veracyte reported FCF Margin of 31.82% as of Q3 2025, which was up 79000.0% from 24.83% recorded in Q2 2025.
  • In the past 5 years, Veracyte's FCF Margin ranged from a high of 31.82% in Q3 2025 and a low of 113.77% during Q1 2021
  • Its 5-year average for FCF Margin is 2.01%, with a median of 9.8% in 2022.
  • As far as peak fluctuations go, Veracyte's FCF Margin plummeted by -946000bps in 2021, and later skyrocketed by 970600bps in 2022.
  • Over the past 5 years, Veracyte's FCF Margin (Quarter) stood at 11.29% in 2021, then fell by -13bps to 9.8% in 2022, then soared by 36bps to 13.29% in 2023, then increased by 29bps to 17.18% in 2024, then soared by 85bps to 31.82% in 2025.
  • Its last three reported values are 31.82% in Q3 2025, 24.83% for Q2 2025, and 3.1% during Q1 2025.